Bain Capital Life Sciences Investors, 10% Owner of Rapid Micro Biosystems RPID, has filed 5 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $90M. The latest trade was on 05/20.

BI

BI

Bain Capital Life Sciences Investors

10% Owner

Company

Rapid Micro Biosystems RPID

First filing

23/05/30

Trades

28 trades

Buys / sales

5 / 5

12-month net buying

−$90M

Last trade

05/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
HeartflowHTFL	Open-market sale	04/28–04/30	04/30	2,000,000 sh4 trades	$29.45avg.	$58,898,336.45	−19.1%
Kailera TherapeuticsKLRA	Open-market buy	04/20	04/20	1,562,500 sh	$16.00	$25,000,000	+7.4%
HeartflowHTFL	Open-market sale	02/04	02/06	2,000,000 sh	$28.05	$56,100,000	−16.1%
Solid BiosciencesSLDB	Open-market buy	25/02/19	25/02/21	1,000,000 sh	$4.03	$4,030,000	+24.8%
Olema PharmaceuticalsOLMA	Open-market buy	25/01/08	25/01/13	300,000 sh	$5.76	$1,728,000	+4.0%
Kyverna TherapeuticsKYTX	Open-market buy	24/02/12	24/02/14	450,000 sh	$22.00	$9,900,000	+16.6%
AnnexonANNX	Open-market buy	23/05/25	23/05/30	300,000 sh	$2.13	$639,000	+5.6%